Synthetic peptide corresponding to residues in Human MEF2A.
This product is a recombinant rabbit monoclonal antibody.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab109420 in the following tested applications.
|WB||1/10000 - 1/50000. Predicted molecular weight: 55 kDa.Can be blocked with MEF2A peptide (ab151761).|
|ICC/IF||1/100 - 1/250.|
ab109420 has not yet been referenced specifically in any publications.